Mark J. Ratain to Inactivation, Metabolic
This is a "connection" page, showing publications Mark J. Ratain has written about Inactivation, Metabolic.
Connection Strength
0.123
-
Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping. Pharmacogenomics. 2006 Dec; 7(8):1211-21.
Score: 0.072
-
Pharmacogenetics in cancer treatment. Annu Rev Med. 2003; 54:437-52.
Score: 0.051